Highlights bioMérieux

Stocks

BIM

FR0013280286

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-07-17 am EDT			5-day change	1st Jan Change
73.00 ^EUR	+0.41%		+4.58%	-33.82%

Jul. 16	MedTech facing a three-front squeeze
Jul. 14	Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026	CI

Highlights

Jul. 14	Biomérieux Showcases Latest Diagnostic Solutions and Innovations At ADLM 2026	CI
Jul. 08	BioMérieux Launches Gene-Up Probiotic Species Id Pcr Solution For Species-Level Identification In Dietary Supplements Manufacturing	CI
Jun. 30	Biomérieux Submits 510(K) to U.S. Fda for Latest Versions of Biofire Filmarray Gastrointestinal Panels to Enhance Detection of Gastrointestinal Pathogens	CI
Jun. 26	BioMérieux Files Dual 510(K) / CLIA Waiver Application To FDA For BIOFIRE SPOTFIRE Vaginitis Panel	CI
Jun. 18	BioMérieux Introduces Salmonella Testing Kit on GENE-UP TYPER to Support Root Cause Analysis in the Food Industry	CI
May. 29	Biomérieux Invests EUR 250 Million to Build New Manufacturing Facility in France	CI
May. 29	BioMérieux to Spend EUR250 Million on New French Manufacturing Facility	MT
May. 27	Minaris Advanced Therapies, LLC Expands Rapid Mycoplasma Detection Services With bioMérieux's BIOFIRE Platform To Reduce Turnaround Time For Release And In-Process Testing	CI
May. 06	L'Institut Merieux: bought an extra 1% in Biomérieux, bringing its total stake in company to around 60%	RE
Apr. 23	BioMerieux: Disappointing Q1 and lower guidance undermine investor confidence
Apr. 23	Biomerieux Q1 sales EUR 984 million	RE
Apr. 20	BioMérieux S.A.Announces Multi-Country Health Economic Analysis Assessing Impact of Deploying Fast Identification and Antimicrobial Susceptibility Testing Early in Care Pathway for Patients with Bloodstream Infections At High-Risk of Sepsis	CI
Apr. 13	RBC Capital Favors Diasorin Over bioMérieux
Apr. 09	BioMérieux Unveils Biofire Spotfire Molecular Testing Solution For The Pharmaceutical Industry	CI
Mar. 19	Biomérieux gets IVDR CE-marking for 2 Biofire Spotfire panels	RE
Mar. 04	BioMérieux S.A. announces Annual dividend, payable on June 11, 2026	CI
Mar. 02	BioMérieux Still Has Upside Potential, Says All Invest Securities
Feb. 27	BioMerieux: 2025 promise delivered; 2026 targets in sight
Feb. 27	BioMérieux
Feb. 27	BioMérieux Expects Revenue Growth Between 5% and 7% in 2026
Feb. 27	Biomérieux eyes 2026 sales growth of 5-7% LFL	RE
Feb. 26	BioMérieux S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Feb. 18	BioMerieux Launches SMARTBIOME to Help Food Manufacturers Gain Deeper Insights into Spoilage and Protect Product Quality	CI
Feb. 02	Oddo BHF Voices Concerns Over Currency Impact and Weaker Flu Season for bioMérieux
Jan. 22	BioMérieux Acquires Remaining 90% Stake in Accellix